Global High-Throughput Screening Services for Drug Discovery Market Growth (Status and Outlook) 2024-2030

Global High-Throughput Screening Services for Drug Discovery Market Growth (Status and Outlook) 2024-2030

To carry out high-throughput screening experiments, facilities often employ automated instruments and liquid handlers in order to test many samples quickly and efficiently. High-throughput screening (HTS) services offer researchers easy access to the experience, expertise, and instrumentation needed to conduct a variety of assays to advance processes in drug discovery and development. HTS applications include enzyme activity assays, molecular binding assays, protein-protein interactions, gene expression screening, compound library screening, cell-based assays, and GPCR assays. HTS-based services often can be tailored to customized requests and the unique requirements of the project. Service providers can also provide technical and scientific advice from the early stages of the project to completion and data analysis.

The global High-Throughput Screening Services for Drug Discovery market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “High-Throughput Screening Services for Drug Discovery Industry Forecast” looks at past sales and reviews total world High-Throughput Screening Services for Drug Discovery sales in 2022, providing a comprehensive analysis by region and market sector of projected High-Throughput Screening Services for Drug Discovery sales for 2023 through 2029. With High-Throughput Screening Services for Drug Discovery sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world High-Throughput Screening Services for Drug Discovery industry.

This Insight Report provides a comprehensive analysis of the global High-Throughput Screening Services for Drug Discovery landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on High-Throughput Screening Services for Drug Discovery portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global High-Throughput Screening Services for Drug Discovery market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for High-Throughput Screening Services for Drug Discovery and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global High-Throughput Screening Services for Drug Discovery.

United States market for High-Throughput Screening Services for Drug Discovery is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for High-Throughput Screening Services for Drug Discovery is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for High-Throughput Screening Services for Drug Discovery is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key High-Throughput Screening Services for Drug Discovery players cover Eurofins Discovery, Charles River Laboratories, Axcelead, NUVISAN, Axxam S.p.A., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of High-Throughput Screening Services for Drug Discovery market by product type, application, key players and key regions and countries.

Segmentation by Type:
Chemical-based HTS Assays
Biological-based HTS Assays
Cell-based HTS Assays
Genetic-based HTS Assays

Segmentation by Application:
Pharmaceutical Company
Biotechnology Company

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Chemical-based HTS Assays
Biological-based HTS Assays
Cell-based HTS Assays
Genetic-based HTS Assays

Segmentation by Application:
Pharmaceutical Company
Biotechnology Company

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Eurofins Discovery
Charles River Laboratories
Axcelead
NUVISAN
Axxam S.p.A.
Evotec
Selvita
Azenta Life Sciences
Bienta (Enamine)
Cayman Chemical
Creative Biolabs
Creative Bioarray
BOC Sciences
MEDICILON
Domainex
Creative Diagnostics
Multispan
AntalGenics
Creative Biostructure
BPS Bioscience

Please note: The report will take approximately 2 business days to prepare and deliver.